Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOP

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2004 by Corixa Corporation.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Corixa Corporation
ClinicalTrials.gov Identifier:
NCT00022932
First received: August 16, 2001
Last updated: June 23, 2005
Last verified: September 2004
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given